Global Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA), By End user(Academic & research institutions, diagnostic labs) - Industry Forecast 2024-2031

Report ID: SQMIG35H2150 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 64 | Figures: 75

Global Gene Amplification Technologies Market News

In December 2023, NGeneBio said that the company has registered a domestic patent for its tuberculosis (TB) diagnostic technology based on next-generation sequencing (NGS) technology. The patent is the “Composition for gene amplification for detecting mycobacterium tuberculosis and determining drug resistance and its use.”

In January 2023, Moderna, Inc. acquired OriCiro Genomics K.K. for $85 million, who will provide expertise on cell-free DNA synthesis and amplification technologies.
In November 2022, a partnership between Merck, a renowned scientific and technological organisation, and Biotheus, a biotech company with headquarters in China that specialises in developing treatments for cancer and autoimmune diseases, was announced. By utilising Merck's Blazar Rodent Panel, Biotheus' turn-around-time (TAT) for characterising its cell lines decreased from approximately 60 days to 14 days.

Global Gene Amplification Technologies Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, at a CAGR of 10% during the forecast period (2024-2031).

The global gene amplification technologies market features intense competition among key players striving to innovate and capture market share. Established companies like Thermo Fisher Scientific, Illumina, and QIAGEN continue to dominate, leveraging their extensive R&D capabilities and diverse product portfolios. Meanwhile, emerging players such as Bio-Rad Laboratories and Agilent Technologies are rapidly gaining ground through disruptive advancements and strategic collaborations. The market's trajectory is shaped by ongoing technological advancements, increasing demand for personalized medicine, and a growing focus on genetic research across pharmaceutical, biotech, and academic sectors, driving players to continually enhance their offerings to maintain a competitive edge. 'Thermo Fisher Scientific (USA)', 'Roche Diagnostics (Switzerland)', 'Agilent Technologies (USA)', 'QIAGEN (Netherlands)', 'Bio-Rad Laboratories (USA)', 'Illumina (USA)', 'Beckman Coulter (USA)', 'Fluidigm Corporation (USA)', 'Merck KGaA (Germany)', 'BioMérieux (France)', 'GenMark Diagnostics (USA)', 'Cepheid (USA)', 'Luminex Corporation (USA)', 'Enzo Biochem (USA)', 'Takara Bio (Japan)', 'Sysmex Corporation (Japan)', 'Promega Corporation (USA)', 'Becton, Dickinson and Company (USA)', 'DiaSorin S.p.A. (Italy)', 'Eppendorf (Germany)'

The increasing demand for personalized medicine and advancements in biotechnology are propelling the growth of the global gene amplification technologies market, as these technologies enable accurate and efficient analysis of genetic material for diagnostic and research purposes.

The global gene amplification technologies market is witnessing key trends such as rapid advancements in CRISPR-Cas9 technology, enabling precise and efficient gene editing. Growing applications in medical research, agriculture, and biotechnology are driving market expansion. Additionally, the rise of synthetic biology and personalized medicine fuels demand for gene amplification tools. Automation and high-throughput capabilities are enhancing efficiency. However, ethical and regulatory concerns regarding genetic manipulation remain challenges. Overall, the market is propelled by innovation, diverse applications, and increasing investment in genetic research, with a focus on both therapeutic and non-therapeutic applications.

North America and Europe were likely the largest markets for gene amplification technologies due to their established biotechnology industries, extensive R&D capabilities, and supportive regulatory frameworks. These regions have a long history of innovation in the life sciences and biotechnology sectors.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA), By End user(Academic & research institutions, diagnostic labs) - Industry Forecast 2024-2031

Global Gene Amplification Technologies Market News

Global Gene Amplification Technologies Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Gene Amplification Technologies Market?

Who are the key vendors in the Global Gene Amplification Technologies Market?

What is the key driver of Global Gene Amplification Technologies Market?

What is the key market trend for Global Gene Amplification Technologies Market?

Which region accounted for the largest share in Global Gene Amplification Technologies Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300